These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 27588392)

  • 1. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma.
    Li R; Huang J; Ma M; Lou Y; Zhang Y; Wu L; Chang DW; Zhao P; Dong Q; Wu X; Han B
    Oncotarget; 2016 Oct; 7(42):68360-68370. PubMed ID: 27588392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
    Chiou SH; Wang ML; Chou YT; Chen CJ; Hong CF; Hsieh WJ; Chang HT; Chen YS; Lin TW; Hsu HS; Wu CW
    Cancer Res; 2010 Dec; 70(24):10433-44. PubMed ID: 21159654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
    Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
    Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of OCT4 expression in adenocarcinoma of the lung.
    Zhang X; Han B; Huang J; Zheng B; Geng Q; Aziz F; Dong Q
    Jpn J Clin Oncol; 2010 Oct; 40(10):961-6. PubMed ID: 20462980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
    Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
    Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.
    Roudi R; Madjd Z; Ebrahimi M; Najafi A; Korourian A; Shariftabrizi A; Samadikuchaksaraei A
    Tumour Biol; 2016 Sep; 37(9):11843-11859. PubMed ID: 27048287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung adenocarcinoma resistance to therapy with EGFR‑tyrosine kinase inhibitors is related to increased expression of cancer stem cell markers SOX2, OCT4 and NANOG.
    Hu F; Li C; Zheng X; Zhang H; Shen Y; Zhou L; Yang X; Han B; Zhang X
    Oncol Rep; 2020 Feb; 43(2):727-735. PubMed ID: 31894290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 9. Positive Feedback Loop of OCT4 and c-JUN Expedites Cancer Stemness in Liver Cancer.
    Kuo KK; Lee KT; Chen KK; Yang YH; Lin YC; Tsai MH; Wuputra K; Lee YL; Ku CC; Miyoshi H; Nakamura Y; Saito S; Wu CC; Chai CY; Eckner R; Steve Lin CL; Wang SS; Wu DC; Lin CS; Yokoyama KK
    Stem Cells; 2016 Nov; 34(11):2613-2624. PubMed ID: 27341307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4
    Liu L; Zhu H; Liao Y; Wu W; Liu L; Liu L; Wu Y; Sun F; Lin HW
    Biomed Pharmacother; 2020 Jul; 127():110225. PubMed ID: 32428834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jorunnamycin A Suppresses Stem-Like Phenotypes and Sensitizes Cisplatin-Induced Apoptosis in Cancer Stem-Like Cell-Enriched Spheroids of Human Lung Cancer Cells.
    Sumkhemthong S; Chamni S; Ecoy GU; Taweecheep P; Suwanborirux K; Prompetchara E; Chanvorachote P; Chaotham C
    Mar Drugs; 2021 May; 19(5):. PubMed ID: 34063628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putative stemness markers octamer-binding transcription factor 4, sex-determining region Y-box 2, and NANOG in non-small cell lung carcinoma: A clinicopathological association.
    Upadhyay VA; Shah KA; Makwana DP; Raval AP; Shah FD; Rawal RM
    J Cancer Res Ther; 2020; 16(4):804-810. PubMed ID: 32930122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation.
    Kumar SM; Liu S; Lu H; Zhang H; Zhang PJ; Gimotty PA; Guerra M; Guo W; Xu X
    Oncogene; 2012 Nov; 31(47):4898-911. PubMed ID: 22286766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of tumor initiation and expression of KCNMA1, MORF4L2 and ASPM genes in the adenocarcinoma of lung xenograft after vorinostat treatment.
    Kuo WY; Wu CY; Hwu L; Lee JS; Tsai CH; Lin KP; Wang HE; Chou TY; Tsai CM; Gelovani J; Liu RS
    Oncotarget; 2015 Apr; 6(11):8663-75. PubMed ID: 25796627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.
    Wang P; Gao Q; Suo Z; Munthe E; Solberg S; Ma L; Wang M; Westerdaal NA; Kvalheim G; Gaudernack G
    PLoS One; 2013; 8(3):e57020. PubMed ID: 23469181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
    Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
    J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma.
    Park E; Park SY; Sun PL; Jin Y; Kim JE; Jheon S; Kim K; Lee CT; Kim H; Chung JH
    Oncotarget; 2016 Jul; 7(27):42502-42512. PubMed ID: 27285762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating of OCT-4 and NANOG was differentially regulated by a new derivative indole in leukemia cell line.
    Karimabad MN; Mahmoodi M; Jafarzadeh A; Darehkordi A; Hajizadeh MR; Khorramdelazad H; Sayadi AR; Rahmani F; Hassanshahi G
    Immunol Lett; 2017 Oct; 190():7-14. PubMed ID: 28690187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Cellular Transforming Activity of OCT4, NANOG, and SOX2 in Immortalized Astrocytes.
    Seo S; Jeon HY; Kim H
    DNA Cell Biol; 2017 Nov; 36(11):1000-1009. PubMed ID: 28933914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.